Carat retains $1.2bn media business in the US

Aegis Media has landed its second Pfizer account in a week, as the pharmaceutical giant has retained Carat to its estimated $1.2bn US media planning and buying business.

Pfizer: retains Carat for media business in the US
Pfizer: retains Carat for media business in the US

The agency held on to the business following a review in September. The agency has worked with Pfizer for 11 years in the US.

The appointment comes after the pharmaceutical giant consolidated all media buying for its Wyeth DTC brands under Carat earlier this year. Intermediary Joanne Davis Consulting handled the review.

Pfizer also works with TargetCast on its media planning and buying account in the US. That relationship is unaffected.

Last week, Aegis-owned Vizeum won Pfizer's £9m media planning and buying business in the UK for its over-the-counter medicine brands.

Vizeum won the pitch against PHD, Maxus and Starcom. Incumbent ZenithOptimedia did not repitch.


Become a member of Campaign

Get the very latest news and insight from Campaign with unrestricted access to, plus get exclusive discounts to Campaign events.

Become a member

What is Campaign AI?

Our new premium service offering bespoke monitoring reports for your company.

Find out more

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an alert now

Partner content